Channels (Austin, Tex.)最新文献

{"title":"Piezo1-mediated fluid shear stress promotes OPG and inhibits RANKL via NOTCH3 in MLO-Y4 osteocytes.","authors":"Zhongcheng Liu,&nbsp;Yuchen Tang,&nbsp;Liangzhi He,&nbsp;Bin Geng,&nbsp;Fan Lu,&nbsp;Jinwen He,&nbsp;Qiong Yi,&nbsp;Xuening Liu,&nbsp;Kun Zhang,&nbsp;Lifu Wang,&nbsp;Yayi Xia,&nbsp;Jin Jiang","doi":"10.1080/19336950.2022.2085379","DOIUrl":"https://doi.org/10.1080/19336950.2022.2085379","url":null,"abstract":"<p><p>Piezo1, a mechanosensitive ion channel, participates in a variety of biological processes in maintaining bone homeostasis. As the most abundant cells in bones of the mammals, osteocytes play an essential role in bone formation, remodeling, and bone mass maintenance. Here, by exposing MLO-Y4 osteocytes to the fluid shear stress (FSS) microenvironment, we explored the effect of Piezo1-mediated FSS on the expression of the molecules critical to the process of bone formation and resorption, Receptor Activator of Nuclear Factor-Kappa-B Ligand (RANKL) and Osteoprotegerin (OPG). It was found that 9 dyne/cm² loading for 30 minutes showed an upregulation trend on Piezo1 when MLO-Y4 osteocytes were exposed to an FSS microenvironment. FSS promotes the expression of OPG and inhibits the expression of RANKL. The blocker of Piezo1, GsMTx4, downregulates the effect of FSS on the expression of these two molecules. In addition, NOTCH3 was involved in this process. Thus, the results demonstrated that Piezo1-mediated FSS promotes the expression of OPG and inhibits the expression of RANKL via NOTCH3 in MLO-Y4 osteocytes.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"127-136"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40400598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability.","authors":"Siyuan Zhao, Tibor Rohacs","doi":"10.1080/19336950.2021.1908781","DOIUrl":"10.1080/19336950.2021.1908781","url":null,"abstract":"<p><p>Transient Receptor Potential Melastatin 3 (TRPM3) is a Ca²⁺ permeable nonselective cation channel, activated by heat and chemical agonists, such as the endogenous neuro-steroid Pregnenolone Sulfate (PregS) and the chemical compound CIM0216. TRPM3 is expressed in peripheral sensory neurons of the dorsal root ganglia (DRG), and its role in noxious heat sensation in mice is well established. TRPM3 is also expressed in a number of other tissues, including the brain, but its role there has been largely unexplored. Recent reports showed that two mutations in TRPM3 are associated with a developmental and epileptic encephalopathy, pointing to an important role of TRPM3 in the human brain. Subsequent reports found that the two disease-associated mutations increased basal channel activity, and sensitivity of the channel to activation by heat and chemical agonists. This review will discuss these mutations in the context of human diseases caused by mutations in other TRP channels, and in the context of the biophysical properties and physiological functions of TRPM3.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"386-397"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25589730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An emerging spectrum of variants and clinical features in <i>KCNMA1</i>-linked channelopathy.","authors":"Jacob P Miller, Hans J Moldenhauer, Sotirios Keros, Andrea L Meredith","doi":"10.1080/19336950.2021.1938852","DOIUrl":"10.1080/19336950.2021.1938852","url":null,"abstract":"<p><p><i>KCNMA1</i>-linked channelopathy is an emerging neurological disorder characterized by heterogeneous and overlapping combinations of movement disorder, seizure, developmental delay, and intellectual disability. <i>KCNMA1</i> encodes the BK K⁺ channel, which contributes to both excitatory and inhibitory neuronal and muscle activity. Understanding the basis of the disorder is an important area of active investigation; however, the rare prevalence has hampered the development of large patient cohorts necessary to establish genotype-phenotype correlations. In this review, we summarize 37 <i>KCNMA1</i> alleles from 69 patients currently defining the channelopathy and assess key diagnostic and clinical hallmarks. At present, 3 variants are classified as gain-of-function with respect to BK channel activity, 14 loss-of-function, 15 variants of uncertain significance, and putative benign/VUS. Symptoms associated with these variants were curated from patient-provided information and prior publications to define the spectrum of clinical phenotypes. In this newly expanded cohort, seizures showed no differential distribution between patients harboring GOF and LOF variants, while movement disorders segregated by mutation type. Paroxysmal non-kinesigenic dyskinesia was predominantly observed among patients with GOF alleles of the BK channel, although not exclusively so, while additional movement disorders were observed in patients with LOF variants. Neurodevelopmental and structural brain abnormalities were prevalent in patients with LOF mutations. In contrast to mutations, disease-associated <i>KCNMA1</i> single nucleotide polymorphisms were not predominantly related to neurological phenotypes but covered a wider set of peripheral physiological functions. Together, this review provides additional evidence exploring the genetic and biochemical basis for <i>KCNMA1-</i>linked channelopathy and summarizes the clinical repository of patient symptoms across multiple types of <i>KCNMA1</i> gene variants.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"447-464"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39152036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trigeminal neuropathic pain is alleviated by inhibition of Ca_v3.3 T-type calcium channels in mice.","authors":"Marena Montera, Aleyah Goins, Leos Cmarko, Norbert Weiss, Karin N Westlund, Sascha R A Alles","doi":"10.1080/19336950.2020.1859248","DOIUrl":"10.1080/19336950.2020.1859248","url":null,"abstract":"<p><p>In this brief report, we demonstrate that the Ca_v3.3 T-type voltage-gated calcium channel subtype is involved in our FRICT-ION model of chronic trigeminal neuropathic pain. We first showed that the <i>Cacna1i</i> gene encoding Ca_v3.3 is significantly upregulated in whole trigeminal ganglia of FRICT-ION mice compared to controls at week 10 post-injury. We confirmed protein upregulation of Ca_v3.3 compared to controls using Western blot analysis of whole trigeminal ganglia tissues. Finally, we demonstrated that intraperitoneal injection of a selective TAT-based Ca_v3.3 blocking peptide in FRICT-ION mice significantly reduces Ca_v3.3 protein expression at the peak anti-allodynic effect (4 hrs post-injection) of the attenuated neuropathic pain behavior. We also suggest that blockade of Ca_v3.3 may be more effective in attenuating trigeminal neuropathic pain in female than male FRICT-ION mice. Therefore, blocking or attenuating Ca_v3.3 function may be an effective strategy for the treatment of trigeminal neuropathic pain.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"31-37"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38343730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrated analysis of Solute carrier family-2 members reveals SLC2A4 as an independent favorable prognostic biomarker for breast cancer.","authors":"Zhenyu Shi,&nbsp;Jiahao Liu,&nbsp;Fei Wang,&nbsp;Yongqiang Li","doi":"10.1080/19336950.2021.1973788","DOIUrl":"https://doi.org/10.1080/19336950.2021.1973788","url":null,"abstract":"<p><p>Most of <i>Solute carrier family-2</i> (SLC2) members play a key role of facilitative transporters, and glucose transporter (GLUT) proteins encoded by <i>SLC2s</i> can transport hexoses or polyols. However, the function and mechanism of <i>SLC2s</i> remain unclear in human cancers. Here, we explored the dysregulated expression, prognostic values, epigenetic, genetic alterations, and biomolecular network of <i>SLC2s</i> in human cancers. According to the data from public-omicsrepository, <i>SLC2A4</i> (<i>GLUT4</i>) was found to be significantly downregulated in most cancers, and higher messenger RNA (mRNA) expression of <i>SLC2A4</i> significantly associated with better prognosis of breast cancer (BRCA) patients. Moreover, DNA hypermethylation in the promoter of <i>SLC2A4</i> may affect the regulation of its mRNA expression, and <i>SLC2A4</i> was strongly correlated with pathways, including the translocation of <i>SLC2A4</i> to the plasma membrane and PID INSULIN PATHWAY. In conclusion, these results provide insight into <i>SLC2s</i> in human cancers and suggest that <i>SLC2A4</i> could be an unfavorable prognostic biomarker for the survival of BRCA patients.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"555-568"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39389897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma.","authors":"Fucheng Meng, Yafei Xiao, Longxiang Xie, Qiao Liu, Keli Qian","doi":"10.1080/19336950.2021.1909301","DOIUrl":"10.1080/19336950.2021.1909301","url":null,"abstract":"<p><p>As the most common histologic subtype of renal cancer, clear cell renal cell carcinoma (ccRCC) poses a serious threat to public health. However, there are no specific molecular-targeted drugs for ccRCC at present. Human ATP-binding cassette (ABC) transporter family plays an important role in homeostasis maintenance. This study aimed to evaluate the potential diagnostic value of <i>ABC</i> genes in ccRCC. A total of 952 samples of ccRCC patients (707) and controls (245) from three different datasets were included for analysis. Receiver operating characteristic analysis and t-test were used to analyze the differential expression of <i>ABC</i> genes in ccRCC patients and control samples at mRNA level during screening and validations. The Cancer Genome Atlas (TCGA-ccRCC) dataset was utilized to investigate the correlation between ABC genes expression and prognostic value in ccRCC. We then investigated the interactions between <i>ABCG1</i> and proteins in the Comparative Toxicogenomics Database (CTD). Finally, we found that ATP-binding cassette transporter G member 1 (<i>ABCG1</i>) was over-expressed in ccRCC patients compared with healthy samples at mRNA level. Cox regression analysis and Kaplan-Meier analysis showed that ccRCC patients with high <i>ABCG1</i> expression had better overall survival (OS) than those patients with low expression (hazard ratio (HR) = 0.662, <i>p</i> = 0.007). This study demonstrated that <i>ABCG1</i> is a potential diagnostic and prognostic biomarker in ccRCC and discussed the molecular mechanisms underlying the relationship between ccRCC and <i>ABCG1</i>, which might provide guidance for better management and treatment of ccRCC in the future.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"375-385"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25566372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Conductance stability and Na+ interaction with Shab K+ channels under low K+ conditions.","authors":"Froylán Gómez-Lagunas,&nbsp;Elisa Carrillo,&nbsp;Carolina Barriga-Montoya","doi":"10.1080/19336950.2021.1993037","DOIUrl":"10.1080/19336950.2021.1993037","url":null,"abstract":"<p><p>K⁺ ions exert a structural effect that brings stability to K⁺ selective pores. Thus, upon bathing Shab channels in 0 K⁺ solutions the ion conductance, G_K, irreversibly collapses. Related to this, studies with isolated KcsA channels have suggested that there is a transition [K⁺] around which the pore takes one of two conformations, either the low (non-conducting) or high K⁺ (conducting) crystal structures. We examined this premise by looking at the K⁺-dependency of G_K stability of Shab channels within the cell membrane environment. We found that: K⁺ effect on G_K stability is highly asymmetrical, and that as internal K⁺ is replaced by Na⁺ G_K drops in a way that suggests a transition internal [K⁺]. Additionally, we found that external permeant ions inhibit G_K drop with a potency that differs from the global selectivity-sequence of K⁺ pores; the non-permeant TEA inhibited G_K drop in a K⁺-dependent manner. Upon lowering internal [K⁺] we observed an influx of Na⁺ at negative potentials. Na⁺ influx was halted by physiological external [K⁺], which also restored G_K stability. Hyperpolarized potentials afforded G_K stability but, as expected, do not restore G_K selectivity. For completeness, Na⁺ interaction with Shab was also assessed at depolarized potentials by looking at Na block followed by permeation (pore unblock) at positive potentials, in solutions approaching the 0 K⁺ limit. The stabilizing effect of negative potentials along with the non-parallel variation of Na⁺ permeability and conductance-stability herein reported, show that pore stability and selectivity, although related, are not strictly coupled.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"648-665"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39524841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alpha lipoic acid attenuates evoked and spontaneous pain following surgical skin incision in rats.","authors":"Sonja Lj Joksimovic, Nathan Lamborn, Vesna Jevtovic-Todorovic, Slobodan M Todorovic","doi":"10.1080/19336950.2021.1907058","DOIUrl":"10.1080/19336950.2021.1907058","url":null,"abstract":"<p><p>Our previous studies have implicated Ca_V3.2 isoform of T-type Ca2+ channels (T-channels) in the development of postsurgical pain. We have also previously established that different T-channel antagonists can alleviate in vivo postsurgical pain. Here we investigated the analgesic potential of another T-channel blocker and endogenous antioxidant molecule, α-lipoic acid (ALA), in a postsurgical pain model in rats. Our in vivo results suggest that single and repetitive intraperitoneal injections of ALA after surgery or preemptively, significantly reduced evoked mechanical hyperalgesia following surgical paw incision. Furthermore, repeated preemptive systemic injections of ALA effectively alleviated spontaneous postsurgical pain as determined by dynamic weight-bearing testing. We expect that our preclinical study may lead to further investigation of analgesic properties and mechanisms of analgesic action of ALA in patients undergoing surgery.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"398-407"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25599350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"TRPM2 in ischemic stroke: Structure, molecular mechanisms, and drug intervention.","authors":"Qing Wang, Ning Liu, Yuan-Shu Ni, Jia-Mei Yang, Lin Ma, Xiao-Bing Lan, Jing Wu, Jian-Guo Niu, Jian-Qiang Yu","doi":"10.1080/19336950.2020.1870088","DOIUrl":"10.1080/19336950.2020.1870088","url":null,"abstract":"<p><p>Ischemic stroke has a high lethality rate worldwide, and novel treatments are limited. Calcium overload is considered to be one of the mechanisms of cerebral ischemia. Transient receptor potential melastatin 2 (TRPM2) is a reactive oxygen species (ROS)-sensitive calcium channel. Cerebral ischemia-induced TRPM2 activation triggers abnormal intracellular Ca²⁺ accumulation and cell death, which in turn causes irreversible brain damage. Thus, TRPM2 has emerged as a new therapeutic target for ischemic stroke. This review provides data on the expression, structure, and function of TRPM2 and illustrates its cellular and molecular mechanisms in ischemic stroke. Natural and synthetic TRPM2 inhibitors (both specific and nonspecific) are also summarized. The three-dimensional protein structure of TRPM2 has been identified, and we speculate that molecular simulation techniques will be essential for developing new drugs that block TRPM2 channels. These insights about TRPM2 may be the key to find potent therapeutic approaches for the treatment of ischemic stroke.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"136-154"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38827012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma.","authors":"Liang Chen,&nbsp;Zhonghua Yang,&nbsp;Yuan Cao,&nbsp;Yiming Hu,&nbsp;Wei Bao,&nbsp;Dan Wu,&nbsp;Li Hu,&nbsp;Jiaheng Xie,&nbsp;Hongzhu Yu","doi":"10.1080/19336950.2021.1968592","DOIUrl":"https://doi.org/10.1080/19336950.2021.1968592","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. Many patients with hepatocellular carcinoma are diagnosed at an advanced stage because the early symptoms are not obvious. For advanced hepatocellular carcinoma, immunotherapy and targeted therapy seem to be a promising direction. Finding a new prognostic marker for hepatocellular carcinoma and exploring its role in the immune microenvironment is of great value. ABCC transporters have previously been associated with drug resistance in hepatocellular tumors, but the exact mechanism remains unclear. Here, we conducted a study on ABCC5 in HCC and found that the expression of ABCC5 was up-regulated in HCC and was associated with poor prognosis. Further exploration revealed that ABCC5 was associated with immune infiltration of hepatocellular carcinoma. Single-cell analysis revealed a potential relationship between ABCC5 and immune cell differentiation. Therefore, it is significant to continue to explore the role of ABCC5 in hepatocellular carcinoma.</p>","PeriodicalId":72555,"journal":{"name":"Channels (Austin, Tex.)","volume":" ","pages":"541-554"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fc/e4/KCHL_15_1968592.PMC8437464.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39411898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}